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Objective: To collect detailed up-to-date knowledge, using a detailed systematic review of the literature, that is speciﬁc to the condition
of Ekbom Syndrome, also known as Delusional Parasitosis (DP). This article will review: Historical facts, epidemiology, pathogenesis,
clinical features, subtypes and related conditions, associated diseases, psychosocial impact, economic considerations and treatment.
Background: DP is a psychiatric condition and can be the earliest sign of a major psychotic illness. The condition was described as early
as the late 17th century in France. The etiology is neuro-chemical. The classic ‘‘matchbox” and ‘‘specimen” signs can lead to a successful
diagnosis. Treatment is via a multidisciplinary approach.Methods: A detailed search strategy was utilized across six databases led by pre-
speciﬁed keywords (62 in number), followed by the application of database-speciﬁc ﬁlters to scrutinize the hierarchy of literature, from
guidelines, systematic reviews and randomized controlled trials to medical papers with weak evidence, including anecdotal reports. One
article was translated from French. Results: Forty references were used to extract the most relevant data. This article is divided into sec-
tions of topics, starting from methodology to a conclusion. Conclusion: This review article will enable the medical researcher to obtain a
detailed perspective of the condition of DP. Thus, a researcher can seek the highest available evidence from the literature and use it as a
starting point for his original research.
 2015 The Author. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The ﬁlters (limits) that were applied across the searched databases.
Database Applied ﬁlters
PubMed English language
Full text search
Publication date in the last 5 years, were a priority
Human studies only
Systematic reviews, guidelines, RCTs &
multicenter studies
The Cochrane
Library
English language
Publication date 2010 to 2015, were a priority
Human studies only
Full text search
Top of the medical evidence hierarchy, were the
prime target
English language
Scopus Articles and reviews under the topic of ‘‘Medicine”
Literatures from all countries
Humans only
Open Gray N/A
Meta Register of
controlled trials
N/A1. Materials and methods
A detailed search strategy was utilized across ﬁve
databases: PubMed, The Cochrane Library, Scopus,
metaRegister of Controlled Trials, and Open Gray. The
search was conducted from June 15 to August 1, 2015.
The search was led by an exhaustive list of pre-
speciﬁed keywords of free text, Medical Subject Headings
(MeSH), and their combination. The number of key-
words reached 62, and they were categorized into ﬁve
main groups: delusional parasitosis (DP) disease nomen-
clature and related terminology, gender categorization,
age groups, terminology of investigative modalities, and
therapeutics’ terminology. Boolean operators and trunca-
tion were used to narrow and expand the search,
respectively.
This was followed by the application of database-
speciﬁc ﬁlters (Tables 1-1 and 1-2). However, some restric-
tions (ﬁlters) were not applicable (N/A) due to the nature
of some databases. Additionally, inclusion and exclusion
criteria (Table 1-3) were created to scrutinize the hierarchy
of available medical literature, from guidelines, systematic
reviews, and randomized controlled trials (RCTs) to med-
ical papers with weak evidence (including anecdotal
reports).
The Critical Appraisal Skills Programme (CASP)
appraisal tool was used to evaluate the papers from the ﬁl-
tered search results. This tool was practical and convenient
due to a number of reasons. Many articles failed (scored
low) during the analysis via the CASP tool due to multiple
factors (Table 1-4). Among the appraised papers that were
used to create this review article; four papers scored the1-1
umber of papers before and after the application of ﬁlters (limits).
PubMed The Cochrane
Library
Sco
umber of papers before limits’
lication
212 9 2
umber of papers after limits’
lication
25 14 1highest. These four papers were heavily used in the citation
of this literature review paper. It’s worthy to mention that
Lepping et al., 2007, was the only systematic review ever
found in the literature search process across 6 diﬀerent
databases. No well-conducted RCTs or other systematic
reviews were found, due to very low incidence of the
disease.pus metaRegister of
Controlled Trials
Open
Gray
Total no. of Articles
(papers)
N/A N/A 223
N/A N/A 40
Table 1-3
Inclusion and exclusion criteria, used to ﬁlter the searched papers.
Inclusion criteria Exclusion criteria
Primary DP, Secondary functional DP, Secondary organic DP, oriﬁcial DP,
Delusory cleptoparasitosis, Delusional Infestation (DI), and Morgellons
disease
Conditions related to the DP, including: Formication, and Illusions of
parasitosis
Females and males (all age groups) Literature of low quality level of evidence was conditionally excluded.
Exclusion was based on low scoring on CASP critical appraisal tool
Literature of high level of evidence
Literature from: Dermatology, Psychiatry, Neurology, Psychology and
Entomology
Table 1-4
The Critical Appraisal Skills Programme (CASP) appraisal tool.
Advantages of CASP tool Causes of low scoring on CASP tool
Less time consuming compared with other appraisal tools (as in
Duﬀy tool)
Small sample size
Appraisal is based on a series of questions (including screening
questions at the beginning)
Weak randomization methods, allocation concealing and blinding techniques in case of
Randomized Controlled Trials (RCTs)
Each question has a hint to guide you through the evaluated
paper
High levels of bias
Two screening questions (at the beginning of CASP) Short duration of studies
Questions covered the entire sections of the evaluated paper No considerable follow up period
Questions were categorized into: validity, results and the
application of results
No data concerning the relapse rate
Questions are answered by: ‘‘Yes”, ‘‘No” and ‘‘Can’t tell” Lack of data on long term safety issues for certain therapeutic agents
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An in-depth analysis of the papers extracted via
database search engines (Tables 2-1 and 2-2, Figs. 1-1
and 1-2), revealed:
 Out of 223 papers (prior to the application of ﬁlters and
limits), only 40 papers (ﬁlters applied) were utilized for
citation and referencing of this literature review paper.
Out of the 40 cited references, only four papers scored
with the highest level of evidence. These were thor-
oughly used in the citation of this paper.Table 2-1
Analysis of the utilized references.
Web Textbook Case
report
Retrospective &
cross sectional stu
Number of paper 7 1 15 4
Level of evidence N/A N/A Low Low
Year Before 2010 N/A 0 7 1
After 2010 N/A 1 8 3
Table 2-2
Papers that scored with the highest level of evidence.
Title
Antipsychotic treatment of primary delusional parasitosis
Delusional parasitosis: a new pathway for diagnosis and treatment
Ekbom syndrome: The challenge of ‘‘invisible bug” infestations
Morgellons in dermatology In the references, there were 7 types of papers: websites,
textbooks, case reports, retrospective and cross-
sectional studies, reviews and systematic reviews and
others (where categorization of type of study was not
applicable).
 The four papers (of the highest evidence) were review
articles (3) and systematic reviews (1). In his systematic
review, Lepping et al., 2007, studied the Antipsychotic
treatment of primary of DP. It was the only systematic
review found in the searched literature.dies
Reviews &
systematic reviews
Guidelines Others Total no.
of papers
6 0 7 40
Variable (Moderate to high) N/A N/A N/A
4 (one systematic review included) N/A 7 19
2 N/A 0 14
Author Type
Lepping et al. (2007) Systematic review
Lepping and Freudenmann (2008) Review article
Hinkle (2010) Review article
Harth et al. (2010) Review article
Figure 1-1. A pie chart for analysis of the relative contribution of
searched papers.
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Patients with Delusional Parasitosis (DP), also known
as Ekbom syndrome (ES), have the false/unshakeable belief
that organisms/bugs are living in the skin and sometimes in
other parts of the body. In young patients, DP can be the
earliest sign of a major psychotic illness. It was ﬁrst
described by Thiebierge & Perrin (Table 3). Alistair MunroOthers
18%
Guidelines
0%
Reviews &
Systemac reviews
15%
Retrospecve &
studies
10%
Figure 1-2. A pie chart for analysis of the typeconsidered it a type of monosymptomatic hypochondriacal
psychosis. Karl Ekbom described its principal manifesta-
tions in 1937–1938. In 1978, a pivotal monograph (by
Annika Skott) with the term Dermatozoenwahn (coined
by Ekbom) was published. Regarding a similar non-
synonymous condition (but within the same delusional
complex) called Morgellons disease, ﬁrst described by
Thomas Browne in 1690, named it ’’Morgellons disease’’,
which refers to a local area in France. She considered it a
re-emergence of this ancient malady, which aﬀected
children of the Languedoc region of France in the 17th
century, in which delusional skin infestation was by
inanimate materials rather than bugs. Somatic delusions
are among the most diﬃcult conditions to treat in
dermatology, and dermatologists must be suﬃciently
prepared to treat them; classical treatment is with anti-
psychotics. (Millard and Millard, 2010; Lee, 2008;
Bourgeois, 2011; Hinkle, 2010; Szepietowski et al., 2007;
Harth et al., 2010).
4. Epidemiology and demographics
Psycho-cutaneous disorders are more common in
females; however, DP aﬀects both sexes equally below
50 years of age, and the male-to-female ratio of having
the disease is 1:3. DP is considered rare (Table 4); however,
Ekbom stated that it is common for mentally ill people to
believe they have creatures in and/or on the body. DP
aﬀects 2.37–17/million/year. The age of onset ranges from
55 to 68 years; however, primary DP may occur in adoles-
cents, and those in the age group of 20–40 years must be
dealt with the utmost concern due to recreational drugs
that may trigger or cause DP. The average duration ofWeb
17%
Textbook
Case report
38%
of papers that were utilized as references.
Table 3
Historical landmarks & scientiﬁc progression in Delusional Parasitosis (DP). Sources: Bourgeois (2011), Harth et al. (2010), Hinkle (2010), Lee (2008),
Millard and Millard (2010) and Szepietowski et al. (2007).
Scientist Year Event
Thomas Browne 1690 1st description of Morgellons disease in France
Thiebierge & Perrin 1894, 1896 1st description of DP
Karl Axel Ekbom 1937–1938 Described the principal features of DP
Annika Skott 1978 Pivotal monograph on DP, with the title term ‘‘Dermatozoenwahn”, was published
Mary Leitao 2002 Used the term ’’Morgellons disease’’
Table 4
Szepietowski et al. (2007) survey, dermatologists encountering cases of Delusional Parasitosis (DP). Source: Szepietowski et al. (2007).
Period of practice Dermatologists participating in the survey Notes
Whole practice 84.7% Saw at least 1 case
Whole practice 28% Treated 3–5 cases
Past 5 years 23% Diagnosed no cases
Past 5 years 7% Saw more than 10 cases
N/A 20% Were currently treating a case of DP
40.7% Always asked for a psychiatric opinion about DP cases
28.8% Often asked for a psychiatric opinion about DP cases
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socio-economic, racial or peculiar predilections; however,
social demographics can be a factor. Many ES-suﬀerers
are intelligent, high-functioning, professionals, medical
professionals and even psychologists. (Millard and
Millard, 2010; Hinkle, 2010; Szepietowski et al., 2007;
Harth et al., 2010; Ehsani et al., 2009; Olari, 2011).Table 5-2
Multifactorial contribution to the pathogenesis of delusional parasitosis in
elderly people. Source: Hinkle (2010).
Senile pruritus
Increased incidence of diabetes mellitus-associated diabetic neuropathy
Reduced visual acuity
Reduced blood ﬂow due to arterial stenosis (produces paresthesia)
Loss of autonomy, leading to depression & low self-esteem
Polypharmacy in the elderly
Frequent taking of over-the-counter drugs/supplements/herbal
remedies
Other medical conditions5. Pathogenesis
DP may evolve as sensory misinterpretation that trans-
forms into a tactile hallucination and consolidates into
delusions, or a hallucination that progresses to somatic
delusion. To understand the pathogenesis, it is essential
to know the DP subtypes (Table 5-1) (Hinkle, 2010;
Wikipedia, n.d.):
DP’s exact etiology is multifactorial. It is of a neuro-
chemical base, and this is conﬁrmed by DP-triggering by
psychoactive agents, such as cocaine and amphetamine,
its association with neuro-hormonal disorders and the
aging process (Table 5-2) (eMedicine, n.d.).
Huber et al. (2008) proposed that decreased striatal
dopamine transportation (DAT) leading to increased
extracellular dopamine underlies DP pathogenesis, and this
was conﬁrmed by Millard and Millard (2010):Table 5-1
Main classiﬁcation/subtypes of delusional parasitosis. Sources: Hinkle (2010)
Type of DP Causes/association
Primary/true/autochthonous Independent of any medical or associated psy
functioning
Secondary functional Associated with psychiatric conditions, such a
Secondary organic Caused by medical illness or recreational subs Primary DAT inhibitors (cocaine, pemoline, bupropion,
amphetamines & others).
 Secondary DAT dysfunction (Parkinson’s disease, brain
injury & others).
Huber et al. (2008) made the ﬁrst structural MRI study
showing the relevance of structural lesions in the corpus
striatum (mainly the putamen) in secondary organic DP.
This caused disturbed functioning of the putamen (which
mediates motor & visuo-tactile perception) and associated
brain areas of the somatic dorsal striato-thalamo-cortical
loop. Moreover, the involvement of the striatum and the
eﬃcacy of antidopaminergic-antipsychotics in treating DP
indicate dopaminergic dysfunction in DP. Freudenmannand Wikipedia (n.d.).
chiatric condition, there is no additional deterioration of basic mental
s schizophrenia and depression
tance abuse
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tors in mediating the anti-psychotics’ eﬀect and gave the
ﬁrst evidence of fronto-striato-thalamo-parietal brain cir-
cuits in mediating Delusional Infestation (DI), which is in
the same spectrum as DP (Millard and Millard, 2010;
Hinkle, 2010; Wikipedia, n.d.; eMedicine, n.d.; Brewer
et al., 2008; Huber et al., 2008; Freudenmann et al., 2010;
Bury and Bostwick, 2010).
6. Clinical features
Presentation can be diverse, and patients are regular vis-
itors to hospitals, persisting in their need for a cure. More
advanced/established cases involve repeated consultations
to specialist services (emergency physicians, family physi-
cians, entomologists, veterinary services and even esteemed
scientists) to eradicate the imagined infestation. Patients
may present with ill-deﬁned, persistent itching without evi-
dent delusions (Millard and Millard, 2010). This is some-
times accompanied by the cutaneous sensation of bugs
(formication), or even visual conﬁrmation of bugs, involve-
ment of the genital, oral or ocular areas (oriﬁcial DP)
(Millard and Millard, 2010; Wikipedia, n.d.). Pruritus is
reported in more than 80% of suﬀerers, and others describeTable 6-1
Variants, subtypes and conditions related to Delusional Parasitosis (DP). Sou
Millard and Millard (2010), Prolosˇcˇic´ et al. (2012) and Wikipedia (n.d.).
Condition Description/notes
Primary DP No organic or psychiatric causes
Secondary functional
DP
Associated with other psychiatric conditions
Secondary organic DP Caused by medical illness or recreational substance
Oriﬁcial DP A variant of DP involving body oriﬁces
Delusory
cleptoparasitosis
A form of DP; patients think the organism is in th
Delusional infestation
(DI)
Includes both DP & delusion of infestation with in
et al., 2011; Hylwa et al., 2012)
Morgellons disease Includes delusional infestation with cognitive defec
Wikipedia, n.d.)
Formication Similar to DP, but patients are not delusional (i.e. th
Illusions of parasitosis Produced by actual physical causes. As insulation/st
such as formalin, produce dermatitis, such individu
(Hinkle, 2010)
Table 6-2
Case reports of interest, association with secondary Delusional Parasitosis (DP)
Omar et al. (2009).
DP association Study/year Description/notes
Thalamic pain syndrome Hanihara et al.
(2009)
Due to left-posterior thalam
developed delusional oral p
Fronto-Temporal lobar
degeneration (FTLD)
Omar et al.
(2009)
Among 8 cases, only 2 show
(Omar et al., 2009)
Topiramate-induced DP Fleury et al.
(2008)
1st reported case of TPM-in
epilepsy (Fleury et al., 2008
Dopamine agonist-induced DP Flann et al.
(2010)
Three cases of DP in patien
dopamine agonists. DP resocrawling, burrowing and biting. Attempts to extract the
bugs produce extensive skin excoriations, which can also
present with bruising, traumatic alopecia, contact dermati-
tis and scarring (Harth et al., 2010; Hinkle, 2010; Millard
and Millard, 2010).
To relieve symptoms, the patient uses: Scissors, ﬁles,
needles, penknives and tweezers, and the most disturbed
patients use surgical instruments, chemicals, corrosives
and pesticides. Old self-mutilated lesions appear: Licheni-
ﬁed, excoriated, ecthymatous or crusted (Harth et al.,
2010; Hinkle, 2010; Millard and Millard, 2010). Patients
usually provide a small container (matchbox, pill container
or a sealed plastic bag), classically known as a ‘‘matchbox
sign”, or better called a ‘‘specimen sign”, enclosing the
assumed/imagined organisms. On microscopy, samples
appear to be hair, skin, fabric, dust, dirt, serum, ants and
ﬂeas, but devoid of real pathogenic organisms
(Freudenmann et al., 2010; Millard and Millard, 2010).
The patient may even provide detailed description(s)
and/or drawing(s) of the organisms’ movement/life cycle
(Millard and Millard, 2010). A scientist claimed he had dis-
covered a new insect that infested his skin, and he made
detailed sketches of the insect and its copulation as seen
by him under microscopy (Hinkle, 2010).rces: Dewan et al. (2011), Hinkle (2010), Hylwa et al. (2012), Lee (2008),
abuse
eir dwelling
animate objects. Patients usually have other psychiatric disorders (Dewan
ts/behavioral changes/tiredness & others (Lee, 2008; Prolosˇcˇic´ et al., 2012;
ey can be convinced with evidence that they do not have a real infestation.)
atic electricity/fragments that feel like stings & various allergens/materials,
als are not delusional and are convinced when the condition is explained
. Source: Flann et al. (2010), Fleury et al. (2008), Hanihara et al. (2009) and
ic hemorrhage, the patient initially suﬀered thalamic pain syndrome, then
arasitosis (Hanihara et al., 2009)
ed DP; others showed more prominent paranoid & somatic delusions
duced DP during course of Rx of 48-year-old woman with temporal lobe
)
ts with well-established Parkinson’s disease, all of whom were taking
lved rapidly when oﬀending drug was stopped (Flann et al., 2010)
Table 6-3
Disorders associated with secondary Delusional Parasitosis (DP). Source:
Millard and Millard (2010).
Systems Disease/disorder
Neurological Dementia and neurodegenerative diseases
Parkinson’s disease
Huntington’s disease
CNS tumors
Head injuries
Encephalitis
Meningitis
Multiple sclerosis
Learning disability
Cardiovascular disorders Arrhythmias
Heart failure
Coronary artery bypass
Renal diseases Chronic renal failure
Dialysis
Liver disease Hepatitis
Endocrine disease Diabetes mellitus
Hyperthyroidism
Hypothyroidism
Panhypopituitarism
Hyperparathyroidism
Acromegaly
Nutritional disorders Pellagra
Folate deﬁciency
Vitamin B12 deﬁciency
Anorexia nervosa
Infectious diseases Syphilis
AIDS
Tuberculosis
Leprosy
Malignancy Breast cancer
Colon cancer
Lung cancer
Lymphoma
Chronic lymphatic leukemia
Substance abuse Amphetamines
Cannabis
Cocaine
Ecstasy
Opiates
Medicines Corticosteroids
Ciproﬂoxacin
Meﬂoquine
Pemoline
Phenelzine
Pargyline
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About 5–15% of patients have associated delusion with
a close relative; these are mostly female family members or
sympathetic/submissive/socially and culturally-isolated
individuals. Such delusions are called ‘‘folie a` deux”, ‘‘folie
a` trois” and ‘‘folie a famille” (folie is the French word for
‘‘madness”). Recently, the role of the media and internet
has been observed in shared delusions (referred to as ‘‘folie
a` Internet” or ‘‘cyberchondria”). The quality of life of the
patient and their family members is severely jeopardized.
(Millard and Millard, 2010; Harth et al., 2010;
Wikipedia, n.d.; Daniel and Srinivasan, 2004).
6.2. Variants, subtypes and related conditions
Many variants, subtypes and related conditions of DP
exist (Table 6-1). Similarly, there are numerous conditions
that may coexist with DP (Millard and Millard, 2010; Lee,
2008; Hinkle, 2010; Wikipedia, n.d.; Hylwa et al., 2012;
Dewan et al., 2011; Prolosˇcˇic´ et al., 2012).
6.3. Associated diseases
DP can occur in disease, aﬀecting the non-dominant
hemisphere, as in Cerebro-Vascular Accidents (CVA).
Structural brain abnormalities that have been reported
include subcortical vascular encephalopathy and right
hemisphere stroke in the temporo-parietal cortex. Simi-
larly, DP can be a part of senile dementia. It has also been
described in pellagra, B12-deﬁciency, after coronary bypass
surgery, as a side-eﬀect of phenelzine, severe renal disease
and others (Tables 6-1–6-3). In a young adult, recreational
drug abuse must be considered (Millard and Millard, 2010;
Brewer et al., 2008; Huber et al., 2008; Hanihara et al.,
2009; Omar et al., 2009; Fleury et al., 2008; Flann et al.,
2010).
6.4. Histopathology
Skin histology is completely normal without speciﬁc
ﬁndings; however, secondary lesions due to rubbing,
scratching and picking. While other patients, may attempt
to persecute the invisible organism or the inanimate subject
can lead to licheniﬁcation, excoriations, ecthymatous
changes, bruising, traumatic-alopecia, contact dermatitis
and scarring. (eMedicine, n.d.; Harth et al., 2010; Hinkle,
2010; Millard and Millard, 2010).
7. Psychological, social, and economic impact
As in any psychological or physical disﬁguring skin dis-
order, there is a negative impact on body image and self-
esteem. Depression, frustration, anxiety and social phobia
may develop. Even the management of DP is always chal-
lenging and frustrating. To quote a patient’s frustration:
‘‘My creepy crawlies deﬁnitely caused anxiety andagitation. I remember fantasizing about cutting my own
skin open and ripping my leg muscles to shreds”. More-
over, shared delusions (Table 7-1) will jeopardize the qual-
ity of life of both the patient and their family and make
treatment more challenging (AAFP, n.d.; Millard and
Millard, 2010; Sciencebasedmedicine, n.d.).
Suicide is a risk in such patients, and they should be
admitted to hospital and to be carefully monitored. In sev-
ere DP, the physician may persuade the patient that treat-
ment is necessary because of the psychological impact,
Table 7-1
Shared delusion between family members.
Source: Millard and Millard (2010).
Familial relation Percentage
Between sisters 34%
Wife & husband 20%
Mother & child 20%
Between brothers 9%
Fathers & sons 2%
Table 7-2
Boggild et al. (2010) study of social impact in Delusional Parasitosis (DP).
Source: Boggild et al. (2010).
Social impact Percentage of patients
Aﬀected personal life 87
Household members aﬀected 62.5
Decreased employment 62.5
Reduced social contact with family 50
Reduced social contact with non-family 75
Contagiousness was a concern/preoccupation 62.5
Alcohol use/abuse 25
Sedative use/abuse 37.5
Rated medical care as ‘‘poor” 63
Rated medical care as ‘‘very good” 25
Believed there is a cure for their condition 63
Table 7-3
Causes behind high economic impact in Delusional Parasitosis (DP).
Sources: Boggild et al. (2010) and Millard and Millard (2010).
Specialist referrals, doctor shopping/physician odyssey
Utilization of many laboratory/diagnostic resources
Thorough initial work-up, which may be repeated by multiple diﬀerent
physicians
Consumption of the microbiology/parasitology laboratories’ resources
Self-ﬁnanced diagnostic evaluations
Absences from work and consequences of unemployment
Self-imposed limitations on social interaction, family disruption
Utilization of toxic & caustic chemicals/drugs/remedies
Substance abuse
Fears of contagion & social phobia
Referral of DP patients to psychiatry presents a major challenge
Table 8
Step-by-step approach to gain solid rapport with patients of delusional
parasitosis. Source: Harth et al. (2010), Hinkle (2010), Lee (2008) and
Millard and Millard (2010).
First consultation/encounter is crucial
It is important to look, listen & be empathetic
Comfort patient by saying that this condition has been seen/treated
before
Reduce patient’s agitation/preoccupation
Conduct a thorough skin examination
Microbiological/parasitological testing to be conducted of the patient’s
‘‘specimens”
Examine more ‘‘specimens” in the consulting room & laboratories
Pay attention to recreational drug abuse
Avoid being misunderstood by patient as supporting their delusions
Acknowledge that the patient’s symptoms are real (though delusional)
Avoid premature confrontation with patient
Delusional patients who perceive agreement or confrontation are
diﬃcult to treat
Within 2–3 visits, it is possible to start to explore/discuss the whole
illness to patient
Shakeability of delusion can be estimated at this point of time
Start with non-irritating local therapy for self-induced lesions
For patients with anxiety/depression, anti-depressants can be oﬀered
Psychotherapeutics should only be suggested when you gain patient’s
trust
If oﬀered, very few delusional patients would accept an antipsychotic
agent
Psychiatrist help can be utilized in immediate future
Psychiatric colleague can see the patient in the dermatology ward
When starting anti-psychotics, initially it is better to hospitalize
patient.
Family members must ensure/monitor patient’s compliance with
therapy
Be cautious if shared delusion exists among family members
Further management is joint consultation with psychiatry department
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ically and physically-fragile individuals. DP can revolve on
a bio-psycho-social management model in collaboration
with psycho-dermatologists, where stress reduction is piv-
otal (Lawrence-Smith, 2009; Millard and Millard, 2010;
Therapeutique-dermatologique, n.d.). Chronic DP will
eventually result in skin scarring. In all chronic scarring
dermatoses, psychosocial and economic impact are evident
(Tables 7-2 and 7-3) (Boggild et al., 2010; Brown et al.,
2008; Evers et al., 2008; Hong et al., 2008; Koblenzer,
2005; Millard and Millard, 2010).8. Treatment
8.1. Title
The dilemma in DP (especially the primary type) is con-
vincing the patient that their condition is psychiatric.
Therefore, solid doctor-patient trust is essential (Table 8).
If left untreated, DP becomes fortiﬁed against further mea-
sures. Delusion almost never resolves itself naturally, but
there is a 50% chance of remission if a psychotropic drug
is administered early after the onset of symptoms. A
multi-disciplinary approach between physicians, labora-
tory workers, entomologists and pest control organizations
is essential. The physician must struggle until the patient is
motivated to use a speciﬁc therapy, usually a combination
psychiatric and psychosomatic therapy. It is vital to watch
for secondary and self-induced skin lesions, such as cel-
lulites, bruising, traumatic-alopecia, contact dermatitis
and scarring. The underlying cause in secondary DP should
never be forgotten (Harth et al., 2010; Hinkle, 2010; Lee,
2008; Millard and Millard, 2010; Prakash et al., 2008)
(See Fig. 2).
The current ﬁrst-line treatment is risperidone and olan-
zapine (atypical or second-generation anti-psychotics), and
the classical treatment was Pimozide (ﬁrst-generation
1st step is to establish 
solid/trustful doctor-patient 
relationship.
Multi-disciplinary approach 
towards DP.
Treat causes of secondary DP.
1st line treatment is risperidone, 
olanzapine or others (atypical/2nd
generation anti-psychotics). 
2nd-line treatment is 1st-
generation anti-psychotics  
(caution with Pimozide)
New treatments include: depot 
neuroleptics & some new 2nd-
generation antipsychotics.
Treat secondary skin lesions 
(excoriated, infected, etc.). 
Be cautious of shared delusion, 
Rx gets more challenging.
Figure 2. Treatment algorithm for Delusional Parasitosis (DP). Source: Harth et al. (2010), Hinkle (2010), Lee (2008), Millard and Millard (2010) and
Prakash et al. (2008).
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cases; however, due to its risk proﬁle (extrapyramidal and
cardiac toxicity), Pimozide is now the second-line treat-
ment. However, safer ﬁrst-generation treatment includes:
Haloperidol, perphenazine and sulpiride (eMedicine, n.d.;
Harth et al., 2010; Lee, 2008).
Atypical (second-generation) anti-psychotics have a
safer proﬁle and are better tolerated (than Pimozide); how-
ever, major risks include metabolic dysfunction. Risperi-
done (dopamine blocker and serotonin antagonist) treat
DP eﬀectively at 1–8 mg/day. Olanzapine (a higher aﬃnity
serotonin blocker than dopamine antagonist) is eﬀective at
5–10 mg/day. Full remission with second-generation
antipsychotics is accomplished in 75% of cases within
3 months of therapy. Safe ﬁrst-generation treatment is used
as a second-line treatment, with sulpiride (selective dopa-
mine antagonists) at 200–400 mg/day. Hanihara et al.
(2009) reported an unusual association of thalamic pain
syndrome with DP, which was eﬃciently treated within
3 months using Sulpiride (100 mg/day) and amitriptyline
(eMedicine, n.d.; Freudenmann et al., 2010; Hanihara
et al., 2009; Harth et al., 2010; Lee, 2008; Lepping and
Freudenmann, 2008; Millard and Millard, 2010;
Wikipedia, n.d.).
Pimozide (as the second-line option): The initial dose is
2 mg/day, increased by 2 mg/week, up to 12 mg/day; how-
ever, Pimozide can be eﬀective at 2–4 mg/day. If the
patient’s improvement persists, Pimozide is decreased grad-
ually by 1 mg every 1–2 weeks to reach the maintenance
dose or total weaning; however, if the patient deteriorateslater, Pimozide can be restarted in a time-limited fashion
to control an episode rather than continuous treatment.
Similar recurrence may occur with atypical antipsychotics
in DP, DI and Morgellons disease (Bourgeois, 2011;
Hinkle, 2010; Lee, 2008; Millard and Millard, 2010).
8.2. New treatments
Freudenmann et al. (2010) reported the ﬁrst eﬀective use
of aripiprazole (atypical antipsychotic) in drug-induced DI
and ziprasidone in organic DI. Contreras et al. (2012)
reported a good response to Pimozide combined with
ziprasidone, an atypical antipsychotic (with a lower risk
of extrapyramidal manifestation); thus, ziprasidone might
be a good ﬁrst treatment option.
Depot anti-psychotics can be considered in the case
of a patient’s poor compliance with oral medications. To
convince the patient of such an approach (depots), the ‘‘hy
posensitization” motivational strategy is used by explain-
ing to the patient that their condition is analogous to extreme
hypersensitivity of the most peripheral skin nerves. (Millard
and Millard, 2010; Freudenmann et al., 2010; Lepping
and Freudenmann, 2008; Contreras-ferrer et al., 2012;
Freudenmann et al., 2009; Bahmer and Bahmer, 2002).
9. Conclusion
DP is a unique psychosomatic disorder that is challeng-
ing to both the patient and physician, and ﬁrst descriptions
date back to the 17th century. Delusional infestation and
14 A.M.L. Al-Imam / Journal of Dermatology & Dermatologic Surgery 20 (2016) 5–14Morgellons disease are within the same delusional com-
plex. DP is rare with a mean age of onset from the sixth
to seventh decades; however, it may occur from the second
to fourth decades, where recreational substance abuse
should be considered. DP can be either primary or sec-
ondary. Pathogenesis points to central neuro-hormonal
mechanisms. Shared delusion can be a dilemma. The
psycho-socio-economic impact is a massive burden. Treat-
ment is via the multi-sectorial approach with a prime target
to build trust and rapport with the patient to avoid ‘‘physi-
cian odyssey” and psychotherapy using second-generation
anti-psychotics as the ﬁrst line of treatment; however, dis-
ease recurrence is common.Conflict of interest
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